VelosBio operates is a owner and operator of a biotechnology company intended to provide cancer research. Founded in 2017, VelosBio is backed by investors that include T. Rowe Price, Wellington Management, Viking Global Investors, Arix Bioscience, and Foresite Capital and is headquartered in San Diego.